Kyverna Therapeutics’ (KYTX) Insights into Stiff Person Syndrome and Beyond
Jacob Funds, a mutual fund company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Kyverna Therapeutics Inc. (KYTX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GordonMD Global Investments Craig Gordon | 4,244,818 | $37,821,328 | 18.3% | |
| 2. | AIGH Investment Partners Orin Hirschman | 2,795,797 | $24,910,552 | +40% | 1.57% |
| 3. | Deerfield Management James E. Flynn | 2,000,000 | $17,820,000 | 0.19% | |
| 4. | Propel Bio Management Leen Kawas And Richard Kayne | 883,198 | $7,869,294 | +38% | 4.12% |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 845,325 | $7,531,846 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.50 | 133,333 | $999,997.50 | 869,317 | 2025-12-18 | Filing | |
| $7.50 | 133,333 | $999,997.50 | 869,317 | 2025-12-18 | Filing | |
| $22.00 | 583 | $12,826.00 | 583 | 2024-02-12 | Filing | |
| $22.00 | 252,553 | $5,556,166.00 | 252,553 | 2024-02-12 | Filing | |
| $22.00 | 450,000 | $9,900,000.00 | 3,163,868 | 2024-02-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.20 | 23,998 | $292,775.60 | 22,636 | 2025-12-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,126,119 | $36,763,720 | 2.23% | |
| 2. | 3,134,807 | $27,931,130 | 0% | |
| 3. | 2,885,000 | $25,705,350 | 1.53% | |
| 4. | 1,897,451 | $16,906,288 | 0% | |
| 5. | 1,049,430 | $9,352,537 | 0% |
News See All
Wells Fargo Raises Kyverna Therapeutics (KYTX) PT to $27 on Confidence in KYV-101 Stiff Person Syndrome Trial Readout
Kyverna Therapeutics Inc. (NASDAQ:KYTX) is one of the best young stocks with huge upside potential.
12 Best Young Stocks with Huge Upside Potential
On September 15, Tom Sosnoff, Tastylive founder, joined 'Squawk Box' on CNBC to discuss the state of the IPO landscape and what to make of the surge of IPO offerings.
11 Best New Penny Stocks to Buy Right Now
On July 28, the Opening Bid team at Yahoo Finance and Victoria Fernandez, chief market strategist at Crossmark Global Investments, discussed the rise in cheap stock trading and what it can mean for the...
7 Best Nano Cap Stocks To Invest In
In one of our recent articles about 8 Most Undervalued Penny Stocks To Buy According To Analysts, we talked about how many analysts are expecting small caps to perform well in a slowing economy.
Hedge Fund Resource Center